Novozymes Q2 Earnings Top Expectations with Strong Organic Growth; Guidance Raised

Donnerstag, 11.08.2022 08:10 von PLX

• (PLX AI) – Novozymes Q2 sales DKK 4,286 million vs. estimate DKK 4,064 million.
• • Q2 net income DKK 817 million
• • Q2 EBIT DKK 1,110 million vs. estimate DKK 1,059 million
• • Q2 EBIT margin 25.9% vs. estimate 26.1%
• • Q2 organic growth 10% vs. estimate 7.4%
• • Outlook FY organic growth 6-8%, up from 4-8% previously
• • Outlook FY EBIT margin 26-27%, up from 25-26% previously
• • CEO says we expect solid margins and returns despite the significant pressure from input and logistic costs